Skip to content
GLP1-US
Prices checked Wegovy pill $149 Wegovy pen $349 Zepbound $299–449 Foundayo from $149 Ozempic $349 Medicare Bridge $50 Compounded sema $175 All prices →

FDA labels and CMS rules checked Oct 23, 2026

What Is GLP-1 Used For? Every FDA-Approved Use, by Drug

GLP-1 drugs are FDA-approved for type 2 diabetes and weight management, plus four specific conditions: heart risk, MASH liver disease, kidney disease in diabetes and sleep apnea. PCOS and prediabetes are not approved uses.

  • 8 approved uses
  • MASH: accelerated approval
  • PCOS, prediabetes: not approved

We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure

By GLP1-US Editorial TeamUpdated
★ Editor's Choice
Chia Health logo

Chia Health

Our #1 pick for GLP-1 weight loss online

  • One monthly price: clinician, medication and free shipping included
  • Semaglutide or tirzepatide, as a weekly injection or a daily tablet
  • No insurance needed; HSA/FSA and Klarna accepted

Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure

$212.89 first month, then $349/mo

6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.

Get Started Read our Chia Health review

01 The list

GLP-1 Approved Uses, Drug by Drug

Each GLP-1 brand has its own label, and the label decides what the drug is approved for. That is why the same molecule can be "for diabetes" as Ozempic and "for weight loss" as Wegovy. Every use below is paired with diet and physical activity on the label.

UseDrugsMedicare route
Type 2 diabetes (blood sugar)
Approved
Ozempic Dec 5, 2017; Mounjaro May 13, 2022 · Adults; Victoza, Trulicity and Mounjaro also 10+
Ozempic, Mounjaro, Trulicity, Victoza, Ozempic tablets Part D plan
Weight management, adults
Approved
Wegovy Jun 4, 2021; Zepbound Nov 8, 2023; Foundayo Apr 1, 2026 · BMI 30+, or 27+ with a weight-related condition
Wegovy pen and pill, Zepbound, Foundayo, Saxenda GLP-1 Bridge, $50
Weight management, ages 12 to 17
Approved
Saxenda Dec 4, 2020; Wegovy Dec 23, 2022 · Teens with obesity
Wegovy pen, Saxenda Not applicable
Heart attack, stroke and CV death risk, no diabetes needed
Approved
Mar 8, 2024 (pen); Dec 22, 2025 (pill) · Adults with heart disease and obesity or overweight
Wegovy pen and pill Part D plan
Heart risk in type 2 diabetes
Approved
Ozempic Jan 16, 2020; Mounjaro Aug 27, 2026 · Adults with type 2 diabetes
Ozempic, Victoza, Trulicity, Rybelsus, Mounjaro Part D plan
Kidney disease with type 2 diabetes
Approved
Jan 28, 2025 · Adults with type 2 diabetes and CKD
Ozempic Part D plan
MASH (fatty liver) with F2 to F3 fibrosis
Accelerated approval
Aug 15, 2025 · Adults, no cirrhosis
Wegovy pen Part D plan only
Moderate to severe obstructive sleep apnea
Approved
Dec 20, 2024 · Adults with obesity
Zepbound Part D plan only
PCOS (now also called PMOS)
Not FDA-approved for this use
No approval · Off-label; weight indication may apply
None Not a covered use
Prediabetes or diabetes prevention
Not FDA-approved for this use
No approval · Weight indication may apply
None Bridge: BMI 27+ with prediabetes

Sources: section 1 of each prescribing information (Wegovy 06/2026, Ozempic 05/2026, Zepbound 08/2026, Saxenda 02/2026); approval dates from Drugs@FDA. Medicare route per CMS Bridge guidance. Rybelsus is listed by the FDA as to be discontinued.

02 By condition

GLP-1 Uses: One Page per Condition

03 Coverage

Why the Approved Use Changes What You Pay

Insurers decide coverage by diagnosis. A plan that excludes "weight loss drugs" can still pay for the same drug prescribed for a medical condition on its label. Expect prior authorization in both cases.

Commercial plans

Weight-loss coverage is an employer choice. Heart-risk, sleep apnea and MASH requests are often reviewed under separate criteria; UnitedHealthcare, for example, covers Wegovy for heart risk and MASH with prior authorization on plans that exclude weight loss. See UnitedHealthcare, Aetna, Blue Cross.

Medicare

Weight management alone: the GLP-1 Bridge, $50/mo from Jul 1, 2026 to Dec 31, 2027. Diabetes, sleep apnea, MASH or a prescription to cut heart risk: your Part D plan and its copay. Details: Medicare GLP-1 Bridge.

Off-label use

Legal for a doctor to prescribe, but plans rarely pay for it. For PCOS or prediabetes, coverage usually depends on whether you meet the weight indication by BMI. More: GLP-1 cost with insurance.

04 Cost

Self-Pay Prices Do Not Depend on the Use

Manufacturer cash prices are the same whatever the prescription is for. As of October 2026:

Sources: NovoCare, Eli Lilly, read Oct 2026. Every option side by side: GLP-1 cost.

Ro's insurance concierge checks coverage for Wegovy, Ozempic and Zepbound and files prior authorizations. Membership $74 to $149 a month, medication billed separately (Oct 2026).

Have Ro check your coverage

05 FAQ

GLP-1 Uses FAQ

What is GLP-1 used for?
GLP-1 drugs are FDA-approved for type 2 diabetes and for weight management. Specific brands also carry approvals for lowering heart attack and stroke risk (Wegovy), MASH liver disease (Wegovy), kidney disease in type 2 diabetes (Ozempic) and obstructive sleep apnea (Zepbound). PCOS and prediabetes are not approved uses.
What is Wegovy approved for?
Three uses, each with diet and exercise: weight reduction in adults and in children 12 and older with obesity; lowering the risk of heart attack, stroke and cardiovascular death in adults with heart disease and obesity or overweight; and noncirrhotic MASH with F2 to F3 fibrosis in adults, under accelerated approval. The Wegovy pill carries the first two, adults only.
Is Ozempic FDA-approved for weight loss?
No. Ozempic is approved for adults with type 2 diabetes: to control blood sugar, to lower heart risk with established heart disease, and since January 28, 2025 to slow kidney disease. Wegovy is the semaglutide brand approved for weight management.
Can a doctor prescribe a GLP-1 for an unapproved use?
Yes. Prescribing off-label is legal and common, but the FDA has not reviewed the evidence for that use, and insurers rarely pay for it. Your doctor may also find that an approved use, such as weight management at your BMI, already applies.
Does the indication change insurance coverage?
Often, yes. Plans that exclude weight-loss drugs may still cover a GLP-1 for diabetes, heart risk, sleep apnea or MASH, usually with prior authorization. In Medicare, those medical uses go through your Part D plan, while weight management alone goes through the $50 GLP-1 Bridge.
Which GLP-1s are approved for teenagers?
Wegovy injection and Saxenda are approved for weight management from age 12. Zepbound, Foundayo and the Wegovy pill are approved for adults only as of October 2026. Mounjaro, Victoza and Trulicity are approved from age 10, but only for type 2 diabetes.
Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.

Checked against primary sources such as FDA labels, CMS and provider pages
Updated
How we check facts →